A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative Study
Background: Individuals with Parkinson’s disease (PD) develop a significant disease burden over time that contributes to a progressive decline in health-related quality of life. There is a paucity of qualitative research to understand symptoms and impacts in individuals with early-stage PD (i.e., Ho...
Saved in:
Published in | Journal of Parkinson's disease Vol. 12; no. 1; pp. 137 - 151 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.01.2022
Sage Publications Ltd IOS Press |
Subjects | |
Online Access | Get full text |
ISSN | 1877-7171 1877-718X |
DOI | 10.3233/JPD-202457 |
Cover
Abstract | Background:
Individuals with Parkinson’s disease (PD) develop a significant disease burden over time that contributes to a progressive decline in health-related quality of life. There is a paucity of qualitative research to understand symptoms and impacts in individuals with early-stage PD (i.e., Hoehn and Yahr stage 1–2 and ≤2 years since diagnosis).
Objective:
The collection of qualitative data to inform the selection of clinical outcome assessments for clinical trials is advocated by regulators. This patient-centered, multistage study sought to create a conceptual model of symptoms and their impact for individuals with early-stage PD.
Methods:
Symptoms and impacts of PD were gathered from a literature review of qualitative research, a quantitative social media listening analysis, and qualitative patient concept elicitation interviews (n = 35). Clinical experts provided input to validate and finalize the concepts.
Results:
The final conceptual model consisted of 27 symptoms categorized into ‘motor’ or ‘non-motor’ domains, and 39 impacts divided into five domains. Most frequently reported symptoms in early-stage PD were ‘tremors’ (89%), ‘stiffness and rigidity’, and ‘fatigue’ (69%, both). Most frequently reported impacts included ‘anxiety’ (74%), ‘eating and drinking’ (71%), followed by ‘exercise/sport’ and ‘relationship with family/family life’ (66%, both).
Conclusion:
This study provides initial insights relating to the symptom and impact burden of early-stage PD patients. The conceptual model can be used to help researchers to develop and select optimal patient-centered outcomes to measure treatment benefit in clinical trials. These findings could inform future qualitative research and the development of outcomes specifically for early-stage PD patients. |
---|---|
AbstractList | Background: Individuals with Parkinson’s disease (PD) develop a significant disease burden over time that contributes to a progressive decline in health-related quality of life. There is a paucity of qualitative research to understand symptoms and impacts in individuals with early-stage PD (i.e., Hoehn and Yahr stage 1–2 and ≤2 years since diagnosis). Objective: The collection of qualitative data to inform the selection of clinical outcome assessments for clinical trials is advocated by regulators. This patient-centered, multistage study sought to create a conceptual model of symptoms and their impact for individuals with early-stage PD. Methods: Symptoms and impacts of PD were gathered from a literature review of qualitative research, a quantitative social media listening analysis, and qualitative patient concept elicitation interviews (n = 35). Clinical experts provided input to validate and finalize the concepts. Results: The final conceptual model consisted of 27 symptoms categorized into ‘motor’ or ‘non-motor’ domains, and 39 impacts divided into five domains. Most frequently reported symptoms in early-stage PD were ‘tremors’ (89%), ‘stiffness and rigidity’, and ‘fatigue’ (69%, both). Most frequently reported impacts included ‘anxiety’ (74%), ‘eating and drinking’ (71%), followed by ‘exercise/sport’ and ‘relationship with family/family life’ (66%, both). Conclusion: This study provides initial insights relating to the symptom and impact burden of early-stage PD patients. The conceptual model can be used to help researchers to develop and select optimal patient-centered outcomes to measure treatment benefit in clinical trials. These findings could inform future qualitative research and the development of outcomes specifically for early-stage PD patients. Background: Individuals with Parkinson’s disease (PD) develop a significant disease burden over time that contributes to a progressive decline in health-related quality of life. There is a paucity of qualitative research to understand symptoms and impacts in individuals with early-stage PD (i.e., Hoehn and Yahr stage 1–2 and ≤2 years since diagnosis). Objective: The collection of qualitative data to inform the selection of clinical outcome assessments for clinical trials is advocated by regulators. This patient-centered, multistage study sought to create a conceptual model of symptoms and their impact for individuals with early-stage PD. Methods: Symptoms and impacts of PD were gathered from a literature review of qualitative research, a quantitative social media listening analysis, and qualitative patient concept elicitation interviews (n = 35). Clinical experts provided input to validate and finalize the concepts. Results: The final conceptual model consisted of 27 symptoms categorized into ‘motor’ or ‘non-motor’ domains, and 39 impacts divided into five domains. Most frequently reported symptoms in early-stage PD were ‘tremors’ (89%), ‘stiffness and rigidity’, and ‘fatigue’ (69%, both). Most frequently reported impacts included ‘anxiety’ (74%), ‘eating and drinking’ (71%), followed by ‘exercise/sport’ and ‘relationship with family/family life’ (66%, both). Conclusion: This study provides initial insights relating to the symptom and impact burden of early-stage PD patients. The conceptual model can be used to help researchers to develop and select optimal patient-centered outcomes to measure treatment benefit in clinical trials. These findings could inform future qualitative research and the development of outcomes specifically for early-stage PD patients. Individuals with Parkinson's disease (PD) develop a significant disease burden over time that contributes to a progressive decline in health-related quality of life. There is a paucity of qualitative research to understand symptoms and impacts in individuals with early-stage PD (i.e., Hoehn and Yahr stage 1-2 and ≤2 years since diagnosis). The collection of qualitative data to inform the selection of clinical outcome assessments for clinical trials is advocated by regulators. This patient-centered, multistage study sought to create a conceptual model of symptoms and their impact for individuals with early-stage PD. Symptoms and impacts of PD were gathered from a literature review of qualitative research, a quantitative social media listening analysis, and qualitative patient concept elicitation interviews (n = 35). Clinical experts provided input to validate and finalize the concepts. The final conceptual model consisted of 27 symptoms categorized into 'motor' or 'non-motor' domains, and 39 impacts divided into five domains. Most frequently reported symptoms in early-stage PD were 'tremors' (89%), 'stiffness and rigidity', and 'fatigue' (69%, both). Most frequently reported impacts included 'anxiety' (74%), 'eating and drinking' (71%), followed by 'exercise/sport' and 'relationship with family/family life' (66%, both). This study provides initial insights relating to the symptom and impact burden of early-stage PD patients. The conceptual model can be used to help researchers to develop and select optimal patient-centered outcomes to measure treatment benefit in clinical trials. These findings could inform future qualitative research and the development of outcomes specifically for early-stage PD patients. |
Author | Postuma, Ronald B. Staunton, Hannah Leddin, Mathias Rodriguez-Esteban, Raul Kelly, Kim Martinez-Martin, Pablo Weintraub, Daniel Newton, Louise Chaudhuri, K. Ray |
Author_xml | – sequence: 1 givenname: Hannah surname: Staunton fullname: Staunton, Hannah email: hannah.staunton@roche.com organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) – sequence: 2 givenname: Kim surname: Kelly fullname: Kelly, Kim organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) – sequence: 3 givenname: Louise surname: Newton fullname: Newton, Louise organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) – sequence: 4 givenname: Mathias surname: Leddin fullname: Leddin, Mathias organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) – sequence: 5 givenname: Raul surname: Rodriguez-Esteban fullname: Rodriguez-Esteban, Raul organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) – sequence: 6 givenname: K. Ray surname: Chaudhuri fullname: Chaudhuri, K. Ray organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) – sequence: 7 givenname: Daniel surname: Weintraub fullname: Weintraub, Daniel organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) – sequence: 8 givenname: Ronald B. surname: Postuma fullname: Postuma, Ronald B. organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) – sequence: 9 givenname: Pablo surname: Martinez-Martin fullname: Martinez-Martin, Pablo organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34657850$$D View this record in MEDLINE/PubMed |
BookMark | eNptkd9OFTEQxhuCEURufADSxAsTk5V2t93u8cLk5ICKwYgBEu6abjsLhd12bbsk587X8PV8EouHfxp60Zmk3_y-6cwLtO68A4ReUfKuKqtq98vRXlGSknGxhjZpI0QhaHO2fp8LuoG2Y7wk-XBa55rnaKNiNRcNJ5sozfGRShZcKhb5ggAGL7zTMKZJ9firN9Bj3-Hj5TAmP0SsnMEnF2ADPhhGpRO2Du-r0C8zJ1xZF737_fNXxHs2gorwHs_x90yyKbtcAz5Ok1m-RM861UfYvo1b6PTj_snic3H47dPBYn5YaFY1qaAgjKlb3hGmGJtxSlvQMxCNEYJobiqhTdu2QjHNcwTTMlEzoeu2FLpsumoLfVhxx6kdwOj8waB6OQY7qLCUXln574uzF_LcX8umYaWoZxnw-hYQ_I8JYpKXfgou9yzLuqS14BXhWbXz2OaefzflLCArgQ4-xgCd1H_n4W9cbS8pkTe7lHmXcrXLXPL2v5I76pPiNytxVOfw0OITyj93Xa1S |
CitedBy_id | crossref_primary_10_1002_mdc3_70007 crossref_primary_10_3389_fmed_2024_1274688 crossref_primary_10_1002_mdc3_14321 crossref_primary_10_1002_mdc3_14286 crossref_primary_10_1038_s41583_024_00830_0 crossref_primary_10_3233_JPD_230267 crossref_primary_10_3233_JPD_239006 crossref_primary_10_3233_JPD_225122 crossref_primary_10_1007_s00702_024_02796_w crossref_primary_10_3233_JPD_225068 crossref_primary_10_1038_s41598_024_71555_4 crossref_primary_10_3389_fneur_2023_1260445 crossref_primary_10_1007_s40120_024_00632_7 crossref_primary_10_3233_JPD_230109 crossref_primary_10_1016_j_drudis_2022_01_015 crossref_primary_10_1212_WNL_0000000000208028 crossref_primary_10_1111_scs_13258 crossref_primary_10_1007_s40120_022_00375_3 crossref_primary_10_3389_fnins_2022_1026065 |
Cites_doi | 10.1177/1525822X05279903 10.1212/01.WNL.0000058905.71369.97 10.1016/j.parkreldis.2014.08.002 10.1002/mdc3.12833 10.1111/j.1468-1331.2008.02056.x 10.1016/j.jval.2011.06.014 10.1002/mds.26424 10.1212/01.CPJ.0000437017.29917.c9 10.1016/S0140-6736(14)61393-3 10.1002/cfg.456 10.1002/mds.22384 10.1093/ageing/26.5.353 10.1016/j.parkreldis.2019.04.014 10.1016/j.neubiorev.2016.07.010 10.1007/s12264-012-1050-z 10.1002/mds.22340 10.1007/s10578-020-01051-z 10.3390/ijms17060904 10.1186/s41687-017-0013-6 10.1177/1359105311428537 10.1016/j.jval.2017.11.014 10.1212/WNL.96.15_supplement.2697 10.3233/JPD-202346 10.1586/erp.11.106 |
ContentType | Journal Article |
Copyright | 2022 – The authors. Published by IOS Press Copyright IOS Press BV 2022 2022 – The authors. Published by IOS Press 2022 |
Copyright_xml | – notice: 2022 – The authors. Published by IOS Press – notice: Copyright IOS Press BV 2022 – notice: 2022 – The authors. Published by IOS Press 2022 |
DBID | AFRWT AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 5PM |
DOI | 10.3233/JPD-202457 |
DatabaseName | Sage Journals GOLD Open Access 2024 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Neurosciences Abstracts |
DatabaseTitleList | Neurosciences Abstracts CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: AFRWT name: Sage Journals GOLD Open Access 2024 url: http://journals.sagepub.com/ sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | H. Staunton et al |
EISSN | 1877-718X |
EndPage | 151 |
ExternalDocumentID | PMC8842769 34657850 10_3233_JPD_202457 10.3233_JPD-202457 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0R~ 4.4 53G ABDBF ABIVO ABJNI ACGFS ACPQW ACPRK ACUHS ADZMO AENEX AFRHK AFRWT ALMA_UNASSIGNED_HOLDINGS EBD EBS GROUPED_DOAJ HZ~ IOS J8X MET MIO MV1 NGNOM O9- SAUOL SCNPE SFC AAYXX ACHEB CITATION CGR CUY CVF ECM EIF NPM 7TK H13 5PM |
ID | FETCH-LOGICAL-c438t-1e7dd6b5f04a449511bec9e78d770c5d37cdbbb7a4c5bbbedb47647c6b27c28f3 |
IEDL.DBID | AFRWT |
ISSN | 1877-7171 |
IngestDate | Thu Aug 21 14:09:11 EDT 2025 Fri Jul 25 10:04:51 EDT 2025 Thu Jan 02 22:54:26 EST 2025 Tue Jul 01 05:27:01 EDT 2025 Thu Apr 24 23:05:07 EDT 2025 Tue Jun 17 22:27:39 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | symptoms Impacts qualitative research quality of life social media Parkinson’s disease |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by-nc/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c438t-1e7dd6b5f04a449511bec9e78d770c5d37cdbbb7a4c5bbbedb47647c6b27c28f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
OpenAccessLink | https://journals.sagepub.com/doi/full/10.3233/JPD-202457?utm_source=summon&utm_medium=discovery-provider |
PMID | 34657850 |
PQID | 2621675305 |
PQPubID | 2046380 |
PageCount | 15 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8842769 proquest_journals_2621675305 pubmed_primary_34657850 crossref_citationtrail_10_3233_JPD_202457 crossref_primary_10_3233_JPD_202457 sage_journals_10_3233_JPD_202457 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-01-01 |
PublicationDateYYYYMMDD | 2022-01-01 |
PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | London, England |
PublicationPlace_xml | – name: London, England – name: Netherlands – name: London – name: Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands |
PublicationTitle | Journal of Parkinson's disease |
PublicationTitleAlternate | J Parkinsons Dis |
PublicationYear | 2022 |
Publisher | SAGE Publications Sage Publications Ltd IOS Press |
Publisher_xml | – name: SAGE Publications – name: Sage Publications Ltd – name: IOS Press |
References | 2009; 24 2017; 1 2013; 3 2019; 6 1997; 26 2015; 30 2015; 386 2008; 14 2006; 18 2012; 17 2011; 14 2016; 17 2012; 12 2018; 21 2021; 96 2021; 52 2001; 47 2014; 20 2021; 11 2019; 64 2008; 23 2005; 6 2012; 28 2008; 15 Suppl 1 2003; 60 2001; 79 2016; 68 10.3233/JPD-202457_ref17 Hurt (10.3233/JPD-202457_ref25) 2019; 64 Merino-Andreu (10.3233/JPD-202457_ref24) 2003; 60 Tison (10.3233/JPD-202457_ref32) 2013; 3 Moustafa (10.3233/JPD-202457_ref2) 2016; 68 Patrick (10.3233/JPD-202457_ref14) 2011; 14 Goetz (10.3233/JPD-202457_ref29) 2008; 23 Willgoss (10.3233/JPD-202457_ref23) 2021; 52 Kalia (10.3233/JPD-202457_ref31) 2015; 386 Sarkar (10.3233/JPD-202457_ref30) 2016; 17 Kandiah (10.3233/JPD-202457_ref27) 2014; 20 World Medical Association (10.3233/JPD-202457_ref18) 2001; 79 Martinez-Martin (10.3233/JPD-202457_ref4) 2012; 12 Deal (10.3233/JPD-202457_ref5) 2019; 6 Port (10.3233/JPD-202457_ref7) 2021; 11 Guest (10.3233/JPD-202457_ref15) 2006; 18 Poewe (10.3233/JPD-202457_ref1) 2008; 15 Suppl 1 Turner-Bowker (10.3233/JPD-202457_ref16) 2018; 21 Xia (10.3233/JPD-202457_ref3) 2012; 28 Milward (10.3233/JPD-202457_ref11) 2005; 6 Hurt (10.3233/JPD-202457_ref6) 2012; 17 Humphrey (10.3233/JPD-202457_ref22) 2017; 1 Kandiah (10.3233/JPD-202457_ref26) 2009; 24 Donatti (10.3233/JPD-202457_ref10) 2008; 14 Jenkinson (10.3233/JPD-202457_ref28) 1997; 26 Postuma (10.3233/JPD-202457_ref13) 2015; 30 Vinikoor-Imler (10.3233/JPD-202457_ref21) 2021; 96 |
References_xml | – volume: 1 start-page: 9 year: 2017 article-title: A comparison of three methods to generate a conceptual understanding of a disease based on the patients’ perspective publication-title: J Patient Rep Outcomes – volume: 26 start-page: 353 year: 1997 end-page: 357 article-title: The Parkinson’s Disease Questionnaire (PDQ-39): Development and validation of a Parkinson’s disease summary index score publication-title: Age Ageing – volume: 15 Suppl 1 start-page: 14 year: 2008 end-page: 20 article-title: Non-motor symptoms in Parkinson’s disease publication-title: Eur J Neurol – volume: 14 start-page: 9 year: 2008 end-page: 12 article-title: The use of conceptual models, conceptual frameworks, and endpoint models to support label claims of treatment benefit using patient reported outcomes publication-title: ISPOR Connect – volume: 6 start-page: 678 year: 2019 end-page: 686 article-title: The Parkinson’s Disease Activities of Daily Living, Interference, and Dependence Instrument publication-title: Mov Disord Clin Pract – volume: 52 start-page: 654 year: 2021 end-page: 668 article-title: Measuring what matters to individuals with Angelman syndrome and their families: Development of a patient-centered disease concept model publication-title: Child Psychiatry Hum Dev – volume: 23 start-page: 2129 year: 2008 end-page: 2170 article-title: Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results publication-title: Mov Disord – volume: 28 start-page: 39 year: 2012 end-page: 48 article-title: Progression of motor symptoms in Parkinson’s disease publication-title: Neurosci Bull – volume: 14 start-page: 967 year: 2011 end-page: 977 article-title: Content validity–establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 1–eliciting concepts for a new PRO instrument publication-title: Value Health – volume: 17 start-page: 904 year: 2016 article-title: Neuroprotective and therapeutic strategies against Parkinson’s disease: Recent perspectives publication-title: Int J Mol Sci – volume: 96 start-page: 2697 year: 2021 article-title: Cross-sectional profile of most bothersome problems as reported directly by individuals with Parkinson’s disease (2697) publication-title: Neurology – volume: 60 start-page: 1553 year: 2003 end-page: 1554 article-title: Unawareness of naps in Parkinson’s disease and in disorders with excessive daytime sleepiness publication-title: Neurology – volume: 11 start-page: 715 year: 2021 end-page: 724 article-title: People with Parkinson’s disease: What symptoms do they most want to improve and how does this change with disease duration? publication-title: J Parkinsons Dis – volume: 6 start-page: 67 year: 2005 end-page: 71 article-title: Ontology-based interactive information extraction from scientific abstracts publication-title: Comp Funct Genomics – volume: 20 start-page: 1145 year: 2014 end-page: 1148 article-title: Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson’s disease publication-title: Parkinsonism Relat Disord – volume: 3 start-page: 480 year: 2013 end-page: 481 article-title: Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease: FRANCE publication-title: Neurology. Clin Pract – volume: 17 start-page: 1076 year: 2012 end-page: 1088 article-title: The relationship of depression and disease stage to patient perceptions of Parkinson’s disease publication-title: J Health Psychol – volume: 30 start-page: 1591 year: 2015 end-page: 1601 article-title: MDS clinical diagnostic criteria for Parkinson’s disease publication-title: Mov Disord – volume: 21 start-page: 839 year: 2018 end-page: 842 article-title: Informing a priori sample size estimation in qualitative concept elicitation interview studies for clinical outcome assessment instrument development publication-title: Value Health – volume: 12 start-page: 221 year: 2012 end-page: 230 article-title: Quality of life and burden in caregivers for patients with Parkinson’s disease: Concepts, assessment and related factors publication-title: Expert Rev Pharmacoecon Outcomes Res – volume: 79 start-page: 373 year: 2001 end-page: 374 article-title: World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects publication-title: Bull World Health Organ – volume: 47 start-page: 199 year: 2001 end-page: 203 article-title: ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice publication-title: J Postgrad Med – volume: 386 start-page: 896 year: 2015 end-page: 912 article-title: Parkinson’s disease publication-title: Lancet – volume: 68 start-page: 727 year: 2016 end-page: 740 article-title: Motor symptoms in Parkinson’s disease: A unified framework publication-title: Neurosci Biobehav Rev – volume: 64 start-page: 220 year: 2019 end-page: 225 article-title: Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson’s publication-title: Parkinsonism Relat Disord – volume: 18 start-page: 59 year: 2006 end-page: 82 article-title: How many interviews are enough? An experiment with data saturation and variability publication-title: Field Methods – volume: 24 start-page: 605 year: 2009 end-page: 608 article-title: Cognitive decline in early Parkinson’s disease publication-title: Mov Disord – volume: 18 start-page: 59 year: 2006 ident: 10.3233/JPD-202457_ref15 article-title: How many interviews are enough? An experiment with data saturation and variability publication-title: Field Methods doi: 10.1177/1525822X05279903 – volume: 60 start-page: 1553 year: 2003 ident: 10.3233/JPD-202457_ref24 article-title: Unawareness of naps in Parkinson’s disease and in disorders with excessive daytime sleepiness publication-title: Neurology doi: 10.1212/01.WNL.0000058905.71369.97 – volume: 20 start-page: 1145 year: 2014 ident: 10.3233/JPD-202457_ref27 article-title: Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson’s disease publication-title: Parkinsonism Relat Disord doi: 10.1016/j.parkreldis.2014.08.002 – volume: 6 start-page: 678 year: 2019 ident: 10.3233/JPD-202457_ref5 article-title: The Parkinson’s Disease Activities of Daily Living, Interference, and Dependence Instrument publication-title: Mov Disord Clin Pract doi: 10.1002/mdc3.12833 – volume: 15 Suppl 1 start-page: 14 year: 2008 ident: 10.3233/JPD-202457_ref1 article-title: Non-motor symptoms in Parkinson’s disease publication-title: Eur J Neurol doi: 10.1111/j.1468-1331.2008.02056.x – volume: 14 start-page: 967 year: 2011 ident: 10.3233/JPD-202457_ref14 article-title: Content validity–establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 1–eliciting concepts for a new PRO instrument publication-title: Value Health doi: 10.1016/j.jval.2011.06.014 – volume: 30 start-page: 1591 year: 2015 ident: 10.3233/JPD-202457_ref13 article-title: MDS clinical diagnostic criteria for Parkinson’s disease publication-title: Mov Disord doi: 10.1002/mds.26424 – volume: 3 start-page: 480 year: 2013 ident: 10.3233/JPD-202457_ref32 article-title: Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease: FRANCE publication-title: Neurology. Clin Pract doi: 10.1212/01.CPJ.0000437017.29917.c9 – volume: 386 start-page: 896 year: 2015 ident: 10.3233/JPD-202457_ref31 article-title: Parkinson’s disease publication-title: Lancet doi: 10.1016/S0140-6736(14)61393-3 – volume: 14 start-page: 9 year: 2008 ident: 10.3233/JPD-202457_ref10 article-title: The use of conceptual models, conceptual frameworks, and endpoint models to support label claims of treatment benefit using patient reported outcomes publication-title: ISPOR Connect – volume: 6 start-page: 67 year: 2005 ident: 10.3233/JPD-202457_ref11 article-title: Ontology-based interactive information extraction from scientific abstracts publication-title: Comp Funct Genomics doi: 10.1002/cfg.456 – volume: 79 start-page: 373 year: 2001 ident: 10.3233/JPD-202457_ref18 article-title: World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects publication-title: Bull World Health Organ – volume: 24 start-page: 605 year: 2009 ident: 10.3233/JPD-202457_ref26 article-title: Cognitive decline in early Parkinson’s disease publication-title: Mov Disord doi: 10.1002/mds.22384 – volume: 26 start-page: 353 year: 1997 ident: 10.3233/JPD-202457_ref28 article-title: The Parkinson’s Disease Questionnaire (PDQ-39): Development and validation of a Parkinson’s disease summary index score publication-title: Age Ageing doi: 10.1093/ageing/26.5.353 – volume: 64 start-page: 220 year: 2019 ident: 10.3233/JPD-202457_ref25 article-title: Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson’s publication-title: Parkinsonism Relat Disord doi: 10.1016/j.parkreldis.2019.04.014 – volume: 68 start-page: 727 year: 2016 ident: 10.3233/JPD-202457_ref2 article-title: Motor symptoms in Parkinson’s disease: A unified framework publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2016.07.010 – volume: 28 start-page: 39 year: 2012 ident: 10.3233/JPD-202457_ref3 article-title: Progression of motor symptoms in Parkinson’s disease publication-title: Neurosci Bull doi: 10.1007/s12264-012-1050-z – volume: 23 start-page: 2129 year: 2008 ident: 10.3233/JPD-202457_ref29 article-title: Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results publication-title: Mov Disord doi: 10.1002/mds.22340 – volume: 52 start-page: 654 year: 2021 ident: 10.3233/JPD-202457_ref23 article-title: Measuring what matters to individuals with Angelman syndrome and their families: Development of a patient-centered disease concept model publication-title: Child Psychiatry Hum Dev doi: 10.1007/s10578-020-01051-z – ident: 10.3233/JPD-202457_ref17 – volume: 17 start-page: 904 year: 2016 ident: 10.3233/JPD-202457_ref30 article-title: Neuroprotective and therapeutic strategies against Parkinson’s disease: Recent perspectives publication-title: Int J Mol Sci doi: 10.3390/ijms17060904 – volume: 1 start-page: 9 year: 2017 ident: 10.3233/JPD-202457_ref22 article-title: A comparison of three methods to generate a conceptual understanding of a disease based on the patients’ perspective publication-title: J Patient Rep Outcomes doi: 10.1186/s41687-017-0013-6 – volume: 17 start-page: 1076 year: 2012 ident: 10.3233/JPD-202457_ref6 article-title: The relationship of depression and disease stage to patient perceptions of Parkinson’s disease publication-title: J Health Psychol doi: 10.1177/1359105311428537 – volume: 21 start-page: 839 year: 2018 ident: 10.3233/JPD-202457_ref16 article-title: Informing a priori sample size estimation in qualitative concept elicitation interview studies for clinical outcome assessment instrument development publication-title: Value Health doi: 10.1016/j.jval.2017.11.014 – volume: 96 start-page: 2697 year: 2021 ident: 10.3233/JPD-202457_ref21 article-title: Cross-sectional profile of most bothersome problems as reported directly by individuals with Parkinson’s disease (2697) publication-title: Neurology doi: 10.1212/WNL.96.15_supplement.2697 – volume: 11 start-page: 715 year: 2021 ident: 10.3233/JPD-202457_ref7 article-title: People with Parkinson’s disease: What symptoms do they most want to improve and how does this change with disease duration? publication-title: J Parkinsons Dis doi: 10.3233/JPD-202346 – volume: 12 start-page: 221 year: 2012 ident: 10.3233/JPD-202457_ref4 article-title: Quality of life and burden in caregivers for patients with Parkinson’s disease: Concepts, assessment and related factors publication-title: Expert Rev Pharmacoecon Outcomes Res doi: 10.1586/erp.11.106 |
SSID | ssj0000516323 |
Score | 2.3745193 |
Snippet | Background:
Individuals with Parkinson’s disease (PD) develop a significant disease burden over time that contributes to a progressive decline in... Background: Individuals with Parkinson’s disease (PD) develop a significant disease burden over time that contributes to a progressive decline in... Individuals with Parkinson's disease (PD) develop a significant disease burden over time that contributes to a progressive decline in health-related quality of... |
SourceID | pubmedcentral proquest pubmed crossref sage |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 137 |
SubjectTerms | Clinical trials Fatigue Humans Literature reviews Movement disorders Neurodegenerative diseases Parkinson Disease - complications Parkinson Disease - diagnosis Parkinson's disease Patient-Centered Care Patients Qualitative Research Quality of Life Research Report |
Title | A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative Study |
URI | https://journals.sagepub.com/doi/full/10.3233/JPD-202457 https://www.ncbi.nlm.nih.gov/pubmed/34657850 https://www.proquest.com/docview/2621675305 https://pubmed.ncbi.nlm.nih.gov/PMC8842769 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1fb9MwED9t3QsvCMS_wKgswQsPhsZ24nQvqFupxqRNFXRib5EdJ9qkNZ1o-tC3fQ2-Hp-EOzsplCKRl0jJKbHuzvbd-e53AG8t7pKZGwqOnpfgylQZNyKx3MTCCO1kVXnEm_OL9PRSnV0lV3tw3dXCtBxcvqe0KhyRX6xpdlM0mqa4FFJ-OJuOUbxCJfrjqpnnIc7dtdOgJ3QwvZrTmXZBmZBr3tW17cOB0MlQ9OBgNPnybbaJx6ByptJ3g4szrTl6OXFAM_3rh9v7145Ruptb-UeCmN-zJo_gYWtsslHQjsewV9ZPoBmxaQBT5RTapV6d7CQUL66QmJqj3bJFxb6u53fNYr5kpnZsRucJ7LMvqWQ3NfO4yIxKpn312M_7H0s2Dmc9R2zEAjKHxxRnlKm4fgqXk0-zk1Pe9l7ghZJZw-NSO5fapBooo9CJimMU9rDUmdN6UCRO6sJZa7VRRYL30lmlU6WL1ApdiKySz6BXL-ryBTC0AaWrrFTUbbfE7a8waFNWdEljjYvgXcfRvGiByak_xm2ODgpxP0fu54H7EbzZ0N4FOI5_Uh12gsk7hcpFKmL0jnB9i-B5kNHmE1KlBPoziEBvSW9DQCDc22_qm2sPxp1lSuh0GAEjOf_-3e6oXv6f5BU8EFRe4UM8h9Brvq_K12j0NLaP-no8Pp70W73tw_7F9PwXcqwFcw |
linkProvider | SAGE Publications |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NbtQwEB7B9gAXBOIvUGAkuHAwbGzH9nJbtay2pa0q2IreIjtO1EpttmLTQ2-8Bq_HkzC2swvLIpFLDhk50YzjmbHn-wbgjSMvafyIM8q8OJO2MczywjGbc8u1F00TGW8Oj9T0RO6fFqc9jjtgYXoNLt6Fsir6orhY93-34EK83z_eJctyWejbsCWLoTID2BpPPn-drbZWaJ4pERu75UZrRglLnohJ_xpg3RVtxJebZZJ_1HpF9zO5D_f6uBHHydAP4FbdPoRujMeJF5WFXdrQdhN3Eg7xmoRDn7MLnDf45ebyqptfLtC2HmfhaAD3IjoSz1uMFMcY0M8RCPbz-48F7qZjmw84xkSyEenBMRQd3jyCk8nH2c6U9W0UWCWF6Vhea--VK5qhtJLyoTwnu41qbbzWw6rwQlfeOaetrAq6195JraSulOO64qYRj2HQztv6KSCFc8I3TsjQOLcmT1ZZCg-bcAnrrM_g7VKjZdVzjIdWFxcl5RpB-yVpv0zaz-D1SvYqMWv8U2p7aZhyOTdKrnhOiQ4tVRk8STZaDSGkCvw9wwz0mvVWAoFPe_1Je34WebWNkVyrUQYY7Pz7dZtf9ez_Iq_gznR2eFAe7B19eg53eUBNxJ2bbRh0367rFxTLdO5lP3d_AQZS8E0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NbtQwEB7BVkJcEBV_oYVaggsHw8Z24iy3VbertkC1gq3oLbLjWK3UZlfd9NAbr8Hr8STM2NmlyyKRSw4ZOdaM7fnxzDcAby1qycINBEfPS3BlfMGNyCw3qTBCO-l9QLz5cpIfnqrjs-ysC11QLUzHwcV7SqvCGYXDmnb33Hna4VJI-eF4MkLpCpXp-7CF_kzR78HWcPz1-3QVXsG1lsvQ3C0ttObotKQRnPSvAdbV0YaNuZkqeSffK6ig8WN41NmObBiFvQ336uYJtEM2idionCK11HqT7cdaxBskpl5nl2zm2bfbq3k7u1ow0zg2pesBdhQqJNlFwwLMMaMK6FAM9uvHzwUbxaubj2zIItBGgAhnlHh4-xROxwfT_UPetVLglZJFy9NaO5fbzPeVUegTpSnKblDrwmndrzIndeWstdqoKsN37azSudJVboWuROHlM-g1s6Z-AQxNOum8lYqa59aozSqDJqKnRxprXALvlhwtqw5nnNpdXJbobxD3S-R-GbmfwJsV7Tyia_yTancpmHK5PkqRixSdHTyuEngeZbQaQqqcMHz6Ceg16a0ICFN7_UtzcR6wtYtCCZ0PEmAk5z-_25zVy_-T7MGDyWhcfj46-bQDDwUVToTgzS702uub-hWaM6193S3d34qk8V0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Patient-Centered+Conceptual+Model+of+Symptoms+and+Their+Impact+in+Early+Parkinson%E2%80%99s+Disease%3A+A+Qualitative+Study&rft.jtitle=Journal+of+Parkinson%27s+disease&rft.au=Staunton%2C+Hannah&rft.au=Kim%2C+Kelly&rft.au=Newton%2C+Louise&rft.au=Leddin%2C+Mathias&rft.date=2022-01-01&rft.pub=Sage+Publications+Ltd&rft.issn=1877-7171&rft.eissn=1877-718X&rft.volume=12&rft.issue=1&rft.spage=137&rft_id=info:doi/10.3233%2FJPD-202457&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1877-7171&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1877-7171&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1877-7171&client=summon |